Prospective, Randomized Open Trial to Evaluate the Efficacy of Highly Purified Urinary FSH Versus Recombinant FSH in Oocyte Donors Undergoing Controlled Ovarian Stimulation Based on Receptor N680S FSH Gene Polymorphism. Genodon Trial (GENODON)

NCT02625519 Phase 4 UNKNOWN

Exploratory, prospective, randomized, comparative, open trial with control group treated to assess whether the effective use of urinary FSH (uFSH) or recombinant FSH (rFSH) can be influenced by genotype of receptor N680S FSH Gene Polymorphism.

Details

Lead sponsor	Instituto Bernabeu
Phase	Phase 4
Status	UNKNOWN
Enrolment	180
Start date	2015-12
Completion	2019-03

Conditions

• Reproductive Techniques, Assisted

Interventions

• Urinary follicle-stimulating hormone
• Recombinant follicle-stimulating hormone

Primary outcomes

• number of cumulus-oocyte complexes obtained — through study completion, an average of 2 weeks
  number of cumulus-oocyte complexes obtained by follicle puncture at the end of ovarian stimulation

Countries

Spain